251 related articles for article (PubMed ID: 23935934)
1. Functional characterization of stromal osteopontin in melanoma progression and metastasis.
Kumar S; Sharma P; Kumar D; Chakraborty G; Gorain M; Kundu GC
PLoS One; 2013; 8(7):e69116. PubMed ID: 23935934
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin as a therapeutic target for cancer.
Bandopadhyay M; Bulbule A; Butti R; Chakraborty G; Ghorpade P; Ghosh P; Gorain M; Kale S; Kumar D; Kumar S; Totakura KV; Roy G; Sharma P; Shetti D; Soundararajan G; Thorat D; Tomar D; Nalukurthi R; Raja R; Mishra R; Yadav AS; Kundu GC
Expert Opin Ther Targets; 2014 Aug; 18(8):883-95. PubMed ID: 24899149
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
[TBL] [Abstract][Full Text] [Related]
4. Serum osteopontin, an enhancer of tumor metastasis to bone, promotes B16 melanoma cell migration.
Hayashi C; Rittling S; Hayata T; Amagasa T; Denhardt D; Ezura Y; Nakashima K; Noda M
J Cell Biochem; 2007 Jul; 101(4):979-86. PubMed ID: 17390343
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways.
Rangaswami H; Kundu GC
Oncol Rep; 2007 Oct; 18(4):909-15. PubMed ID: 17786354
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1.
Cao J; Li J; Sun L; Qin T; Xiao Y; Chen K; Qian W; Duan W; Lei J; Ma J; Ma Q; Han L
Mol Oncol; 2019 Feb; 13(2):228-245. PubMed ID: 30367545
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin.
Kale S; Raja R; Thorat D; Soundararajan G; Patil TV; Kundu GC
Oncogene; 2014 May; 33(18):2295-306. PubMed ID: 23728342
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway.
Qin X; Yan M; Wang X; Xu Q; Wang X; Zhu X; Shi J; Li Z; Zhang J; Chen W
Theranostics; 2018; 8(4):921-940. PubMed ID: 29463991
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells.
Liu G; Fan X; Tang M; Chen R; Wang H; Jia R; Zhou X; Jing W; Wang H; Yang Y; Yin F; Wei H; Li B; Zhao J
Cancer Lett; 2016 Dec; 383(2):171-182. PubMed ID: 27702661
[TBL] [Abstract][Full Text] [Related]
11. Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.
Sorrentino C; Miele L; Porta A; Pinto A; Morello S
Oncotarget; 2016 Sep; 7(39):64274-64288. PubMed ID: 27590504
[TBL] [Abstract][Full Text] [Related]
12. Direct Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis.
Inada M; Takita M; Yokoyama S; Watanabe K; Tominari T; Matsumoto C; Hirata M; Maru Y; Maruyama T; Sugimoto Y; Narumiya S; Uematsu S; Akira S; Murphy G; Nagase H; Miyaura C
J Biol Chem; 2015 Dec; 290(50):29781-93. PubMed ID: 26475855
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin has a protective role in prostate tumor development in mice.
Danzaki K; Kanayama M; Alcazar O; Shinohara ML
Eur J Immunol; 2016 Nov; 46(11):2669-2678. PubMed ID: 27601131
[TBL] [Abstract][Full Text] [Related]
14. The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis.
Chakraborty G; Jain S; Behera R; Ahmed M; Sharma P; Kumar V; Kundu GC
Curr Mol Med; 2006 Dec; 6(8):819-30. PubMed ID: 17168734
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
Glycoconj J; 2006 May; 23(3-4):221-32. PubMed ID: 16691505
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
[TBL] [Abstract][Full Text] [Related]
17. Thrombin cleavage of osteopontin initiates osteopontin's tumor-promoting activity.
Peraramelli S; Zhou Q; Zhou Q; Wanko B; Zhao L; Nishimura T; Leung TH; Mizuno S; Ito M; Myles T; Stulnig TM; Morser J; Leung LLK
J Thromb Haemost; 2022 May; 20(5):1256-1270. PubMed ID: 35108449
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y
Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469
[TBL] [Abstract][Full Text] [Related]
19. Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model.
Chakraborty G; Kumar S; Mishra R; Patil TV; Kundu GC
PLoS One; 2012; 7(3):e33633. PubMed ID: 22448259
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.
Weber CE; Kothari AN; Wai PY; Li NY; Driver J; Zapf MA; Franzen CA; Gupta GN; Osipo C; Zlobin A; Syn WK; Zhang J; Kuo PC; Mi Z
Oncogene; 2015 Sep; 34(37):4821-33. PubMed ID: 25531323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
